ZOE.DEZOE.DEXETRA
Loading
EBITDA Over TimeStrong
Percentile Rank100
3Y CAGR+6.8%
5Y CAGR+8.8%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+6.8%/yr
vs +12.6%/yr prior
5Y CAGR
+8.8%/yr
Consistent
Acceleration
-5.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$4.07B+5.6%
2024$3.85B+5.2%
2023$3.67B+9.7%
2022$3.34B+5.8%
2021$3.16B+18.4%
2020$2.67B+9.5%
2019$2.44B+17.1%
2018$2.08B+7.2%
2017$1.94B+18.8%
2016$1.63B-